Outcomes of MDR/XDR-TB patients treated with linezolid: experience in Thailand.

Background: Multi-drug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB) becomes an increasing problem in management. Linezolid has been off-label used in treatment of MDR/XDR-TB with major adverse effects.

Objective: To study outcomes of MDR/XDR-TB patients treated with linezolid in Central Chest Institute of Thailand.